RLMD - Relmada Therapeutics Inc.'s (RLMD) CEO Sergio Traversa on Q1 2022 Results - Earnings Call Transcript

Relmada Therapeutics, Inc. (RLMD) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors, Investor Relations Sergio Traversa - Chief Executive Officer Maged Shenouda - Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Andrea Tan - Goldman Sachs Yatin Suneja - Guggenheim Partners Marc Goodman - SVB Leerink Vamil Divan - Mizuho Securities Matt Hershenhorn - Oppenheimer Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to the Relmada Therapeutics, Inc. First Quarter 2022 Earnings Call. During the presentation all participants will be in listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded, Thursday, May 5, 2022. I would now like to turn the conference over to Tim McCarthy, LifeSci Advisors. Please go ahead. Tim McCarthy Thank you, Ingrid, and thank you all for joining us this

For further details see:

Relmada Therapeutics, Inc.'s (RLMD) CEO Sergio Traversa on Q1 2022 Results - Earnings Call Transcript